...
首页> 外文期刊>Bioanalysis >Development of an Meso Scale Discovery ligand-binding assay for measurement of free (drug-unbound) target in nonhuman primate serum
【24h】

Development of an Meso Scale Discovery ligand-binding assay for measurement of free (drug-unbound) target in nonhuman primate serum

机译:开发非人类灵长类动物血清中游离(药物 - 未结合)靶标的间谍尺度发现配体结合测定

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To quantify the free form of a protein as a target-engagement biomarker in nonhuman primate serum, a Meso Scale Discovery ligand-binding assay was developed and qualified. Results: The initial assay produced an unexpected artifact when used to measure the free target in study samples dosed with drug. By using incurred study samples dosed with high drug levels to test assay performance, we developed an alternative assay that does not suffer from drug interference. Conclusion: Our work demonstrated that an assay designed to measure free target may not necessarily deliver reliable quantitation. In our case, incurred study samples dosed with drug proved to be useful in developing an alternative free assay that does not suffer from drug interference.
机译:目的:将蛋白质的自由形式量定量为靶接合生物标志物,在非人类灵长类动物血清中,开发和合格。 结果:初始测定用于测量用药物提出的研究样品中的游离靶标产生意外的工件。 通过使用具有高药物水平的诱发的研究样本来测试测定性能,我们开发了一种不患有药物干扰的替代测定。 结论:我们的工作表明,旨在测量自由目标的测定可能不一定能够提供可靠的定量。 在我们的案例中,患有药物引发的研究样本被证明是有助于开发不患有药物干扰的替代自由测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号